|
1
|
Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
|
J Nucl Med
|
2008
|
1.74
|
|
2
|
Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.
|
JACC Cardiovasc Imaging
|
2009
|
1.48
|
|
3
|
Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy).
|
Am Heart J
|
2008
|
0.95
|
|
4
|
Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
|
Eur J Nucl Med Mol Imaging
|
2004
|
0.87
|
|
5
|
Persistent insulin-sensitizing effects of sarpogrelate hydrochloride, a serotonin 2A receptor antagonist, in patients with peripheral arterial disease.
|
Circ J
|
2006
|
0.80
|
|
6
|
Synergistic prognostic values of cardiac sympathetic innervation with left ventricular hypertrophy and left atrial size in heart failure patients without reduced left ventricular ejection fraction: a cohort study.
|
BMJ Open
|
2012
|
0.78
|
|
7
|
Cardiac mortality assessment improved by evaluation of cardiac sympathetic nerve activity in combination with hemoglobin and kidney function in chronic heart failure patients.
|
J Nucl Med
|
2012
|
0.77
|
|
8
|
Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction.
|
J Card Fail
|
2003
|
0.76
|
|
9
|
Incremental prognostic value of stress/rest gated perfusion SPECT in patients with coronary artery disease--subanalysis of the J-ACCESS study.
|
Circ J
|
2009
|
0.75
|